WHO and UN partners’ compendium of 500 actions aims to reduce diseases from environmental factors and save lives
Almost 25% of deaths worldwide could be prevented if the actions in the compendium were fully implemented WHO, UNDP, UNEP and UNICEF have partnered to create a new compendium of 500 actions aimed at reducing death and diseases driven by environmental risk factors, the first such resource to unite this expertise from across the UN […]
World failing to address dementia challenge
Only a quarter of countries worldwide have a national policy, strategy or plan for supporting people with dementia and their families, according to the WHO’s ‘Global status report on the public health response to dementia’, released today. Half of these countries are in WHO’s European Region, with the remainder split between the other Regions. Yet […]
WHO, Germany open hub for pandemic and epidemic intelligence in berlin
New hub’s mission is to provide the world with better data, analytics and decisions to detect and respond to health emergencies Berlin, 1 September 2021 -- To better prepare and protect the world from global disease threats, H.E. German Federal Chancellor Dr Angela Merkel and Dr Tedros Adhanom Ghebreyesus, World Health Organization Director-General, will today […]
Prime Minister’s Dream of TB Free India by 2025
Shri Mansukh Mandaviya, Union Minister of Health and Family Welfare today interacted with State Health Ministers and Principal Secretaries/ Additional Chief Secretaries of all States/UTs in the presence of Dr. Bharati Pravin Pawar, Union Minister of State for Health and Family Welfare, to review the progress made in the fight against TB through focussed and […]
Roche provides update on Tecentriq US indication for PD-L1-positive, metastatic triple-negative breast cancer
Basel, 27 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the company has made the decision to voluntarily withdraw the US accelerated approval for Tecentriq® (atezolizumab) in combination with chemotherapy (Abraxane®, albumin-bound paclitaxel; nab-paclitaxel) for the treatment of adults with unresectable locally advanced or metastatic triple-negative breast cancer (mTNBC) whose tumours […]
Union Minister for Health and Family Welfare and Chemicals & Fertilizers, Shri Mansukh Mandaviya releases first commercial batch of COVAXIN manufactured in Ankleshwar, Gujarat
Union Minister for Health and Family Welfare and Chemical and Fertilizer Shri. Mansukh Mandaviya today released the first commercial batch of COVAXIN from Chiron Behring Vaccines facility of Bharat Biotech in Ankleshwar, Gujarat. Shri C R Patil, MP, Navsari, Shri Ishwarsinh Patel, MLA, Ankleshwar, Shri. Dushyant Patel, MLA and Dr. Krishna Ella, Chairman & Managing […]
Amidst Kabul airport blockage, WHO and UNICEF call for assistance to deliver critical health supplies to Afghanistan
KABUL/CAIRO/KATHMANDU,22 August 2021: “As humanitarian needs in Afghanistan increase, the abilities to respond to those needs are rapidly declining. WHO and UNICEF call for immediate and unimpeded access to deliver medicines and other lifesaving supplies to millions of people in need of aid, including 300 000 people displaced in the last two months alone. “While […]
Digital Covid-19 Vaccination Certificates provided to Clinical Trial Participants of COVISHIELD and COVAXIN through Co-WIN
Indian Council of Medical Research (ICMR) in partnership with Serum Institute of India (SII) had conducted phase II/III bridging studies of COVISHIELD from August 2020. Phase III efficacy clinical trials for COVAXIN were also conducted by Bharat Biotech International Limited (BBIL) from November 2020. The Union Ministry of Health and Family Welfare had received several […]
Science in 5: Do I still need the vaccine if I had COVID-19?
If you had COVID-19, do you still need the vaccine? How long should you wait after recovery to get vaccinated? What do we know about natural immunity vs vaccine-induced immunity? WHO’s Chief Scientist Dr Soumya Swaminathan explains in Science in 5 this week. YouTube Science in 5 episode About WHO The World Health Organization provides global […]
Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy
Cancer is the second leading cause of death worldwide, with nearly 10 million deaths annually.1, 2 In the U.S., approximately 1.9 million new cancer cases are expected to be diagnosed in 2021.1 Based on cancer biomarkers, the first-of-its-kind VENTANA MMR RxDx Panel helps determine which solid tumour patients may benefit from GSK immunotherapy. Roche/GSK collaboration […]
